Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells-Reference-Cited by-同舟云学术

Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells

Published:2021 Issue:27 Volume:50 Page:9500-9511
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Michlewska Sylwia¹²³⁴⁵^ORCID,Maroto Marta⁶⁷⁸⁹,Hołota Marcin⁴⁵³,Kubczak Malgorzata⁴⁵³,Sanz del Olmo Natalia⁶⁷⁸⁹,Ortega Paula⁶⁷⁸⁹¹⁰^ORCID,Shcharbin Dzmitry¹¹¹²¹³^ORCID,de la Mata Francisco Javier⁶⁷⁸⁹¹⁰^ORCID,Bryszewska Maria⁴⁵³^ORCID,Ionov Maksim⁴⁵³^ORCID

Affiliation:

1. Laboratory of Microscopic Imaging & Specialized Biological Techniques. Faculty of Biology & Environmental Protection. University of Lodz

2. Lodz 90-237

3. Poland

4. Department of General Biophysics. Faculty of Biology & Environmental Protection. University of Lodz

5. Lodz 90-236

6. Universidad de Alcalá. Department of Organic and Inorganic Chemistry

7. and Research Institute in Chemistry “Andrés M. del Río” (IQAR)

8. Madrid

9. Spain

10. Networking Research Center on Bioengineering

11. Institute of Biophysics & Cell Engineering of NASB

12. 220072 Minsk

13. Belarus

Abstract

A new family of cationic ruthenium(ii) metallodendrimers of a carbosilane nature with the metal centre coordinated to 2-aminopyridine ligands have been synthesized and interacted with conventional anticancer drugs.

Funder

Narodowa Agencja Wymiany Akademickiej

Narodowe Centrum Nauki

Instituto de Salud Carlos III

European Cooperation in Science and Technology

Ministerio de Economía y Competitividad

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/DT/D1DT01388B